We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Rambus
RMBS
$11B
| $28.7M | 0.01% |
1,130,577
+139,160
| +14% | +$3.48M |
|
777
Ameris Bancorp
ABCB
$5.89B
| $28.7M | 0.01% |
642,071
+16,756
| +3% | +$768K |
|
778
AngloGold Ashanti
AU
$48.7B
| $28.7M | 0.01% |
2,076,963
+679,632
| +49% | +$9.68M |
|
779
Tapestry
TPR
$32.8B
| $28.7M | 0.01% |
1,009,499
-21,783
| -2% | -$728K |
|
780
Progyny
PGNY
$2.2B
| $28.6M | 0.01% |
772,127
+301,511
| +64% | +$11.3M |
|
781
Belden
BDC
$5.19B
| $28.5M | 0.01% |
475,499
+10,070
| +2% | +$641K |
|
782
Yeti Holdings
YETI
$3.95B
| $28.5M | 0.01% |
1,000,583
-63,701
| -6% | -$2.65M |
|
783
First Merchants
FRME
$2.67B
| $28.5M | 0.01% |
737,172
+53,541
| +8% | +$2.12M |
|
784
Innospec
IOSP
$2.28B
| $28.5M | 0.01% |
332,817
-67,864
| -17% | -$6.41M |
|
785
ACI Worldwide
ACIW
$5.42B
| $28.5M | 0.01% |
1,364,024
+97,654
| +8% | +$2.43M |
|
|
CYBR
786
DELISTED
CyberArk
CYBR
| $28.5M | 0.01% |
190,060
-26,115
| -12% | -$3.73M |
|
787
Li Auto
LI
$12.7B
| $28.5M | 0.01% |
1,237,685
+48,700
| +4% | +$1.52M |
|
788
MGM Resorts International
MGM
$11.2B
| $28.4M | 0.01% |
955,485
-123,850
| -11% | -$4.03M |
|
789
Texas Pacific Land
TPL
$23.5B
| $28.4M | 0.01% |
143,712
-3,033
| -2% | -$584K |
|
790
Guardant Health
GH
$22.6B
| $28.3M | 0.01% |
526,384
-193,845
| -27% | -$9.95M |
|
791
Innovative Industrial Properties
IIPR
$1.72B
| $28.3M | 0.01% |
319,698
-2,485
| -0.8% | -$241K |
|
792
HEICO Corp Class A
HEI.A
$37.2B
| $28.2M | 0.01% |
245,834
-9,966
| -4% | -$1.2M |
|
793
Enterprise Products Partners
EPD
$81.7B
| $28.2M | 0.01% |
1,184,728
+373,796
| +46% | +$9.64M |
|
794
Zurn Elkay Water Solutions
ZWS
$8.53B
| $28.1M | 0.01% |
1,147,878
+19,588
| +2% | +$558K |
|
795
BioNTech
BNTX
$23.5B
| $28.1M | 0.01% |
208,395
+55,925
| +37% | +$8.55M |
|
|
DOC
796
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $28.1M | 0.01% |
1,867,980
+269,547
| +17% | +$4.55M |
|
797
Viatris
VTRS
$18.9B
| $28.1M | 0.01% |
3,297,094
-930,761
| -22% | -$9.16M |
|
798
Genpact
G
$5.76B
| $28.1M | 0.01% |
641,056
-104,972
| -14% | -$4.83M |
|
|
APLS
799
DELISTED
Apellis Pharmaceuticals
APLS
| $28M | 0.01% |
410,401
+34,201
| +9% | +$2.02M |
|
800
Zions Bancorporation
ZION
$10.3B
| $28M | 0.01% |
550,531
-16,480
| -3% | -$901K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.